1. Home
  2. HOFV vs SILO Comparison

HOFV vs SILO Comparison

Compare HOFV & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOFV
  • SILO
  • Stock Information
  • Founded
  • HOFV 2015
  • SILO 2010
  • Country
  • HOFV United States
  • SILO United States
  • Employees
  • HOFV N/A
  • SILO N/A
  • Industry
  • HOFV Services-Misc. Amusement & Recreation
  • SILO Apparel
  • Sector
  • HOFV Consumer Discretionary
  • SILO Consumer Discretionary
  • Exchange
  • HOFV Nasdaq
  • SILO Nasdaq
  • Market Cap
  • HOFV 8.2M
  • SILO 8.8M
  • IPO Year
  • HOFV N/A
  • SILO N/A
  • Fundamental
  • Price
  • HOFV $1.18
  • SILO $1.78
  • Analyst Decision
  • HOFV Hold
  • SILO
  • Analyst Count
  • HOFV 1
  • SILO 0
  • Target Price
  • HOFV N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • HOFV 26.9K
  • SILO 9.1M
  • Earning Date
  • HOFV 03-19-2025
  • SILO 02-14-2025
  • Dividend Yield
  • HOFV N/A
  • SILO N/A
  • EPS Growth
  • HOFV N/A
  • SILO N/A
  • EPS
  • HOFV N/A
  • SILO N/A
  • Revenue
  • HOFV $22,529,744.00
  • SILO $72,102.00
  • Revenue This Year
  • HOFV N/A
  • SILO $1.86
  • Revenue Next Year
  • HOFV $10.19
  • SILO N/A
  • P/E Ratio
  • HOFV N/A
  • SILO N/A
  • Revenue Growth
  • HOFV 7.02
  • SILO N/A
  • 52 Week Low
  • HOFV $0.81
  • SILO $0.77
  • 52 Week High
  • HOFV $3.78
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • HOFV 47.63
  • SILO 57.77
  • Support Level
  • HOFV $1.14
  • SILO $1.56
  • Resistance Level
  • HOFV $1.29
  • SILO $1.89
  • Average True Range (ATR)
  • HOFV 0.11
  • SILO 0.19
  • MACD
  • HOFV -0.01
  • SILO -0.04
  • Stochastic Oscillator
  • HOFV 30.53
  • SILO 47.46

About HOFV Hall of Fame Resort & Entertainment Company

Hall Of Fame Resort & Entertainment Co operates as a holding company. The firm is a sports, entertainment, and media company. It generates revenues from various streams such as sponsorship agreements, rents, cost recoveries, events, hotel operations, Hall of Fantasy League, and through the sale of media assets.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: